688799 华纳药厂
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.9029.31812.73011.88615.007
总资产报酬率 ROA (%)2.8537.08810.0979.60511.826
投入资产回报率 ROIC (%)3.3918.52012.04411.34314.505

边际利润分析
销售毛利率 (%)61.03761.63064.78567.71272.385
营业利润率 (%)10.63411.44916.54915.16315.864
息税前利润/营业总收入 (%)9.73910.23015.18414.49415.356
净利润/营业总收入 (%)8.7049.82113.47313.41314.021

收益指标分析
经营活动净收益/利润总额(%)91.55796.83596.90293.02291.016
价值变动净收益/利润总额(%)-4.230-11.5431.5594.0910.948
营业外收支净额/利润总额(%)-0.892-0.055-3.147-0.534-1.034

偿债能力分析
流动比率 (X)4.0273.4214.0134.2344.646
速动比率 (X)2.7952.4362.9343.0833.488
资产负债率 (%)26.42825.90118.77417.43917.695
带息债务/全部投入资本 (%)10.2836.2772.3762.068-0.114
股东权益/带息债务 (%)829.3131,411.6123,980.9374,575.411-84,720.728
股东权益/负债合计 (%)275.867283.082421.701455.722465.140
利息保障倍数 (X)-12.171-8.441-17.654-24.640-44.472

营运能力分析
应收账款周转天数 (天)45.60241.33439.24738.76236.980
存货周转天数 (天)267.489257.343250.413275.918277.521